Biocon Biologics
- All
- News
- Videos
-
CBI Files Charge Sheet In Rs 9 lakh Biocon Bribery Case, 5 Named
The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive, in a Rs nine lakh bribery case.
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
'Walk The Talk', With Kiran Mazumdar Shaw: Full Transcript
This episode of Walk The Talk features Biocon chief Kiran Mazumar Shaw talking about the need to leverage India's strong biology base into innovation.
-
Biocon Releases Novel Drug to Treat Skin Disease
India's leading biotech firm Biocon has unveiled a new drug to treat psoriasis, a skin disease that occurs when the immune system mistakes a normal skin cell for a pathogen."Psoriasis is a socially debilitating disease affecting around three percent of...
-
CBI Files Charge Sheet In Rs 9 lakh Biocon Bribery Case, 5 Named
The CBI has filed a charge sheet against five persons, including a Joint Drug Controller of the Central Drugs Standard Control Organisation(CDSCO) and a Biocon Biologics executive, in a Rs nine lakh bribery case.
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
'Walk The Talk', With Kiran Mazumdar Shaw: Full Transcript
This episode of Walk The Talk features Biocon chief Kiran Mazumar Shaw talking about the need to leverage India's strong biology base into innovation.
-
Biocon Releases Novel Drug to Treat Skin Disease
India's leading biotech firm Biocon has unveiled a new drug to treat psoriasis, a skin disease that occurs when the immune system mistakes a normal skin cell for a pathogen."Psoriasis is a socially debilitating disease affecting around three percent of...
